BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9662945)

  • 1. [Diagnostic pitfalls in sulfonylurea-induced neuroglycopenic syndrome with hemiparesis, dysphasia and somnolence].
    Holstein A; Lankes HG; Egberts EH
    Med Klin (Munich); 1998 Jun; 93(6):374-7. PubMed ID: 9662945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemic--hemiplegia.
    Gupta AK; Dave M; Arora SK; Bhardwaja B
    J Assoc Physicians India; 1994 Jun; 42(6):507. PubMed ID: 7852244
    [No Abstract]   [Full Text] [Related]  

  • 4. [CNS symptoms caused by hypoglycemia: frequent misdiagnosis: "stroke". Pitfall of the neuroglycopenia syndrome].
    Holstein A; Egberts EH
    MMW Fortschr Med; 1999 Jun; 141(22):42-4. PubMed ID: 10468475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
    Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
    Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.
    Gonzalez RR; Zweig S; Rao J; Block R; Greene LW
    Endocr Pract; 2007; 13(4):417-23. PubMed ID: 17669721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia in hospitalized patients treated with sulfonylureas.
    Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
    Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliclazide-induced hepatitis, hemiplegia and dysphasia in a suicide attempt.
    Caksen H; Kendirci M; Tutuş A; Uzüm K; Kurtoğlu S
    J Pediatr Endocrinol Metab; 2001; 14(8):1157-9. PubMed ID: 11592575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual sulfonylureas and serious hypoglycemia in older people.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    J Am Geriatr Soc; 1996 Jul; 44(7):751-5. PubMed ID: 8675920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent?
    Brustman L; Langer O; Scarpelli S; El Daouk M; Fuchs A; Rosenn B
    Obstet Gynecol; 2011 Feb; 117(2 Pt 1):349-353. PubMed ID: 21252749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
    Barkin JA; Block HM; Mendez PE
    Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
    [No Abstract]   [Full Text] [Related]  

  • 15. Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas.
    Bosco-Lévy P; Salvo F
    BMJ; 2016 Aug; 354():i4328. PubMed ID: 27495245
    [No Abstract]   [Full Text] [Related]  

  • 16. Refractory hypoglycemia from ciprofloxacin and glyburide interaction.
    Lin G; Hays DP; Spillane L
    J Toxicol Clin Toxicol; 2004; 42(3):295-7. PubMed ID: 15362597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.
    Tan A; Holmes HM; Kuo YF; Raji MA; Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2015 Feb; 70(2):247-54. PubMed ID: 24858839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.
    Clemens KK; McArthur E; Dixon SN; Fleet JL; Hramiak I; Garg AX
    Can J Diabetes; 2015 Aug; 39(4):308-16. PubMed ID: 25840942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.